Page last updated: 2024-12-07

b 220

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

B 220: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID130705
CHEMBL ID456589
SCHEMBL ID1581068
MeSH IDM0167296

Synonyms (24)

Synonym
2-(2,3-dimethylindolo[3,2-b]quinoxalin-6-yl)-n,n-dimethyl-ethanamine
6h-indolo[2,3-b]quinoxaline-6-ethanamine, n,n,2,3-tetramethyl-
OPREA1_679137 ,
B220 ,
CHEMBL456589
2-(2,3-dimethylindolo[3,2-b]quinoxalin-6-yl)-n,n-dimethylethanamine
9-oh-b220
112228-65-6
b-220
6h-indolo(2,3-b)quinoxaline-6-ethanamine, n,n,2,3-tetramethyl-
b 220
2,3-dimethyl-6-(dimethylaminoethyl)-9-hydroxy-6h-indolo-(2,3-b)quinoxaline
2,3-dimethyl-n,n-dimethylaminoethyl-5h-indolo(2,3-b)quinoxaline
SCHEMBL1581068
CS-0018424
HY-100272
DTXSID40920692
2-(2,3-dimethyl-6h-indolo[2,3-b]quinoxalin-6-yl)-n,n-dimethylethan-1-amine
2,3-dimethyl-6(2-dimethylaminoethyl)-6h-indolo-(2,3-b)quinoxaline
MS-24703
nsc-811922
112229-05-7
nsc811922
AKOS040732520
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID390367Antiviral activity against human cytomegalovirus2008Journal of medicinal chemistry, Dec-25, Volume: 51, Issue:24
Interactions of antiviral indolo[2,3-b]quinoxaline derivatives with DNA.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.24 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.71 (4.65)
Search Engine Demand Index68.89 (26.88)
Search Engine Supply Index2.57 (0.95)

This Compound (40.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]